Abdominal Imaging

The month of November is host to National Stomach Cancer Awareness Month and Gastroesophageal Reflux Disease Week. Radiology plays an important role in diagnosing gastric cancer and GERD.

Transjugular Interhepatic Portosystemic Shunts, or “TIPS,” is now a common alternative treatment for patients with cirrhosis and other forms of advanced liver disease.

New UCSF research confirms that computed tomographic colonography (CTC) administered without laxatives is as accurate as standard colonoscopy in detecting polyps that are clinically significant and potentially cancerous.

Narrowing of the arteries supplying the kidneys, known as renal artery stenosis, is the most common potentially reversible cause of high blood pressure and kidney failure in the U.S., but early diagnosis is critical to prevent permanent and irreversible kidney damage.

March is Colorectal Cancer Awareness Month. Learn about one of the largest studies to date examining the effectiveness of CT Colonography.

UCSF’s world-renowned expertise in prostate cancer and spectroscopic imaging has led our Prostate Cancer Imaging Group to develop a multiparametric magnetic resonance imaging staging exam of prostate cancer.

While, like every procedure, there is the rare potential for complications, prostate cancer biopsies are a potentially life saving medical imaging exam. UCSF strives to mitigate risk, and through state of the art imaging research has developed a specialized exam to reduce the number of required biopsies for patients.

Imaging can contribute substantially to the local and distant evaluation of prostate cancer. However, not all imaging is created equal.

New findings support the use of CTC for accurately evaluating the colon for cancer.

Obesity affects many Americans – including children. Many overweight people can develop liver problems, a condition known as “non-alcoholic fatty liver disease,” or NAFLD. In this condition, there is increased fat in the liver which can cause further liver damage.